2672 related articles for article (PubMed ID: 19597085)
41. [Course of illness and prognosis of multiple sclerosis. 2: Predictive value of clinical and paraclinical factors].
Flachenecker P; Hartung HP
Nervenarzt; 1996 Jun; 67(6):444-51. PubMed ID: 8767198
[TBL] [Abstract][Full Text] [Related]
42. Acute fulminant demyelinating disease: a descriptive study of 60 patients.
de Seze J; Debouverie M; Zephir H; Lebrun C; Blanc F; Bourg V; Wiertlewski S; Pittion S; Laplaud D; Le Page E; Deschamps R; Cabre P; Pelletier J; Malikova I; Clavelou P; Jaillon V; Defer G; Labauge P; Gout O; Boulay C; Edan G; Vermersch P
Arch Neurol; 2007 Oct; 64(10):1426-32. PubMed ID: 17923626
[TBL] [Abstract][Full Text] [Related]
43. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a.
Barkhof F; Rocca M; Francis G; Van Waesberghe JH; Uitdehaag BM; Hommes OR; Hartung HP; Durelli L; Edan G; Fernández O; Seeldrayers P; Sørensen P; Margrie S; Rovaris M; Comi G; Filippi M;
Ann Neurol; 2003 Jun; 53(6):718-24. PubMed ID: 12783417
[TBL] [Abstract][Full Text] [Related]
44. Clinical isolated syndrome: a 3-year follow-up study in China.
Liu Y; Duan Y; Yu C; Qin W; Chen H; Dong H; Ye J; Butzkueven H; Li K
Clin Neurol Neurosurg; 2011 Oct; 113(8):658-60. PubMed ID: 21680087
[TBL] [Abstract][Full Text] [Related]
45. MRI in the diagnosis of pediatric multiple sclerosis.
Callen DJ; Shroff MM; Branson HM; Lotze T; Li DK; Stephens D; Banwell BL
Neurology; 2009 Mar; 72(11):961-7. PubMed ID: 19038852
[TBL] [Abstract][Full Text] [Related]
46. Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis.
Rot U; Mesec A
Clin Neurol Neurosurg; 2006 Mar; 108(3):271-4. PubMed ID: 16378679
[TBL] [Abstract][Full Text] [Related]
47. Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes.
Villar LM; Espiño M; Roldán E; Marín N; Costa-Frossard L; Muriel A; Alvarez-Cermeño JC
Mult Scler; 2011 Jun; 17(6):690-4. PubMed ID: 21436320
[TBL] [Abstract][Full Text] [Related]
48. [Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis].
Sailer M; Fazekas F; Gass A; Kappos L; Radue EW; Rieckmann P; Toyka K; Wiendl H; Bendszus M
Rofo; 2008 Nov; 180(11):994-1001. PubMed ID: 18937154
[TBL] [Abstract][Full Text] [Related]
49. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.
Garg N; Zivadinov R; Ramanathan M; Vasiliu I; Locke J; Watts K; Lema J; Rajeswary J; Munschauer FE; Ambrus J; Weinstock-Guttman B
J Neuroimmunol; 2007 Jul; 187(1-2):159-65. PubMed ID: 17512610
[TBL] [Abstract][Full Text] [Related]
50. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
51. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis.
Di Pauli F; Reindl M; Ehling R; Schautzer F; Gneiss C; Lutterotti A; O'Reilly E; Munger K; Deisenhammer F; Ascherio A; Berger T
Mult Scler; 2008 Sep; 14(8):1026-30. PubMed ID: 18632775
[TBL] [Abstract][Full Text] [Related]
52. [Paraclinical tests in multiple sclerosis. Clinical correlation and predictive value].
Iriarte J; de Castro P; Artieda J; Zubieta JL; Martínez-Lage JM
Neurologia; 1993 Feb; 8(2):53-8. PubMed ID: 8452688
[TBL] [Abstract][Full Text] [Related]
53. [Comparative study of visual evoked potentials and magnetic resonance imaging in multiple sclerosis].
Miletto G; Merlihot JM; Nezri M; Stanoyevitch JF; Pernet-Rambaud C; Houis B
J Fr Ophtalmol; 1988; 11(1):67-73. PubMed ID: 3385127
[TBL] [Abstract][Full Text] [Related]
54. [Multiple sclerosis in Peru. A clinical-epidemiological description of a series of patients].
Vizcarra-Escobar D; Cava-Prado L; Tipismana-Barbarán M
Rev Neurol; 2005 Nov 16-30; 41(10):591-5. PubMed ID: 16288421
[TBL] [Abstract][Full Text] [Related]
55. Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study.
Atzori M; Battistella PA; Perini P; Calabrese M; Fontanin M; Laverda AM; Suppiej A; Drigo P; Grossi P; Rinaldi L; Gallo P
Mult Scler; 2009 Mar; 15(3):363-70. PubMed ID: 18987105
[TBL] [Abstract][Full Text] [Related]
56. Magnetic resonance imaging in isolated noncompressive spinal cord syndromes.
Miller DH; McDonald WI; Blumhardt LD; du Boulay GH; Halliday AM; Johnson G; Kendall BE; Kingsley DP; MacManus DG; Moseley IF
Ann Neurol; 1987 Dec; 22(6):714-23. PubMed ID: 3435080
[TBL] [Abstract][Full Text] [Related]
57. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
[TBL] [Abstract][Full Text] [Related]
58. Clinical characteristics of multiple sclerosis in Lebanon.
Yamout B; Barada W; Tohme RA; Mehio-Sibai A; Khalifeh R; El-Hajj T
J Neurol Sci; 2008 Jul; 270(1-2):88-93. PubMed ID: 18367208
[TBL] [Abstract][Full Text] [Related]
59. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?
Karussis D; Leker RR; Ashkenazi A; Abramsky O
Ann Neurol; 1998 Oct; 44(4):629-34. PubMed ID: 9778261
[TBL] [Abstract][Full Text] [Related]
60. Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.
Marques IB; Matias F; Silva ED; Cunha L; Sousa L
J Clin Neurosci; 2014 Apr; 21(4):583-6. PubMed ID: 24231563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
